These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3941271)

  • 1. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
    Patek PQ; Lin Y; Collins JL; Cohn M
    J Immunol; 1986 Jan; 136(2):741-5. PubMed ID: 3941271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
    Patek PQ; Lin Y
    J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.
    Halachmi E; Witz IP
    Cancer Res; 1989 May; 49(9):2383-9. PubMed ID: 2539901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis.
    Lin Y; Collins JL; Patek PQ; Cohn M
    J Immunol; 1983 Sep; 131(3):1154-9. PubMed ID: 6604090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
    J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of immune surveillance of sequentially derived cell lines that differ in their tumorigenic potential.
    Lin Y; Patek PQ; Collins JL; Cohn M
    J Natl Cancer Inst; 1985 May; 74(5):1025-30. PubMed ID: 3873568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth in vivo selects for resistance to tumor necrosis factor.
    Lattime EC; Stutman O
    J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tumorigenicity of growth factor-dependent versus -independent CCL39 lung fibroblast lines in nude mice.
    Renwick DE; Franchi AJ; Pouysségur JM; Lagarde AE
    J Natl Cancer Inst; 1986 Jul; 77(1):105-14. PubMed ID: 3459908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms.
    Patek PQ; Lin Y; Collins JL
    J Immunol; 1987 Mar; 138(5):1641-6. PubMed ID: 3805728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B; Wright JA; Greenberg AJ
    J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine model for B-cell lymphomagenesis in immunocompromised hosts: natural killer cells are an important component of host resistance to premalignant B-cell lines.
    Felsher DW; Rhim SH; Braun J
    Cancer Res; 1990 Nov; 50(21):7050-6. PubMed ID: 2208172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological and morphological properties of fibroblasts transformed in vitro. II. The change in the susceptibility of FC3H3 cells to lymphocytes--natural killers and macrophages during their selection for malignancy].
    Lavrovskiĭ VA; Iurchenko IuA; Viksler VKh
    Tsitologiia; 1984 Oct; 26(10):1181-5. PubMed ID: 6515718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some immunological properties of high and low tumorigenic cellular variants of c-H-ras transformed 3T3 cells.
    Gonen B; Ran M; Wreschner D; Cahalon L; Anavi R; Shlomo Y; Witz IP
    Nat Immun Cell Growth Regul; 1988; 7(3):144-54. PubMed ID: 3050475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
    Schiller JH; Bittner G
    Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological and morphological properties of in vitro transformed fibroblasts. III. Recognition by macrophages and activated lymphocytes of mouse and rat cells of various degrees of tumorigenicity].
    Lavrovskiĭ VA; Iurchenko IuA; Guvakova MA
    Tsitologiia; 1987 May; 29(5):589-95. PubMed ID: 3617224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that cytotoxic T cells and natural cytotoxic cells use different lytic mechanisms to lyse the same targets.
    Patek PQ; Collins JL; Cohn M
    Eur J Immunol; 1983 May; 13(5):433-6. PubMed ID: 6189729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
    Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
    J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.